Menalled LB - Search Results

1

The Michael J. Fox Foundation for Parkinson's Research Strategy to Advance Therapeutic Development of PINK1 and Parkin.

Padmanabhan S, Polinski NK, Menalled LB, Baptista MAS, Fiske BK. Padmanabhan S, et al. Among authors: menalled lb. Biomolecules. 2019 Jul 24;9(8):296. doi: 10.3390/biom9080296. Biomolecules. 2019. PMID: 31344817 Free PMC article.

2

Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum.

Creed RB, Menalled L, Casey B, Dave KD, Janssens HB, Veinbergs I, van der Hart M, Rassoulpour A, Goldberg MS. Creed RB, et al. Neuroscience. 2019 Jun 15;409:169-179. doi: 10.1016/j.neuroscience.2019.04.033. Epub 2019 Apr 25. Neuroscience. 2019. PMID: 31029729 Free PMC article.

3

A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein.

Merchant KM, Cedarbaum JM, Brundin P, Dave KD, Eberling J, Espay AJ, Hutten SJ, Javidnia M, Luthman J, Maetzler W, Menalled L, Reimer AN, Stoessl AJ, Weiner DM; The Michael J. Fox Foundation Alpha Synuclein Clinical Path Working Group. Merchant KM, et al. J Parkinsons Dis. 2019;9(1):31-61. doi: 10.3233/JPD-181471. J Parkinsons Dis. 2019. PMID: 30400107 Free PMC article.

4

Behavioral responses to injections of muscimol into the subthalamic nucleus: temporal changes after nigrostriatal lesions.

Mehta A, Menalled L, Chesselet MF. Mehta A, et al. Neuroscience. 2005;131(3):769-78. doi: 10.1016/j.neuroscience.2004.11.036. Neuroscience. 2005. PMID: 15730880

5

Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment.

Gafni J, Papanikolaou T, Degiacomo F, Holcomb J, Chen S, Menalled L, Kudwa A, Fitzpatrick J, Miller S, Ramboz S, Tuunanen PI, Lehtimäki KK, Yang XW, Park L, Kwak S, Howland D, Park H, Ellerby LM. Gafni J, et al. J Neurosci. 2012 May 30;32(22):7454-65. doi: 10.1523/JNEUROSCI.6379-11.2012. J Neurosci. 2012. PMID: 22649225 Free PMC article.

6

Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice.

Menalled LB, Sison JD, Wu Y, Olivieri M, Li XJ, Li H, Zeitlin S, Chesselet MF. Menalled LB, et al. J Neurosci. 2002 Sep 15;22(18):8266-76. doi: 10.1523/JNEUROSCI.22-18-08266.2002. J Neurosci. 2002. PMID: 12223581 Free PMC article.

7

R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures.

Cepeda-Prado E, Popp S, Khan U, Stefanov D, Rodríguez J, Menalled LB, Dow-Edwards D, Small SA, Moreno H. Cepeda-Prado E, et al. Among authors: menalled lb. J Neurosci. 2012 May 9;32(19):6456-67. doi: 10.1523/JNEUROSCI.0388-12.2012. J Neurosci. 2012. PMID: 22573668 Free PMC article.

8

Animal models of Huntington's disease for translation to the clinic: best practices.

Menalled L, Brunner D. Menalled L, et al. Mov Disord. 2014 Sep 15;29(11):1375-90. doi: 10.1002/mds.26006. Mov Disord. 2014. PMID: 25216369 Review.

9

Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease.

Lewandowski NM, Bordelon Y, Brickman AM, Angulo S, Khan U, Muraskin J, Griffith EY, Wasserman P, Menalled L, Vonsattel JP, Marder K, Small SA, Moreno H. Lewandowski NM, et al. Neurobiol Dis. 2013 Apr;52:84-93. doi: 10.1016/j.nbd.2012.11.014. Epub 2012 Dec 4. Neurobiol Dis. 2013. PMID: 23220414 Free PMC article.

10

Mouse models of Huntington's disease.

Menalled LB, Chesselet MF. Menalled LB, et al. Trends Pharmacol Sci. 2002 Jan;23(1):32-9. doi: 10.1016/s0165-6147(00)01884-8. Trends Pharmacol Sci. 2002. PMID: 11804649 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page